Nevakar
Bridgewater
About Nevakar
Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space. Their goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts. Nevakar’s business model is supported by state-of-the-art R&D infrastructure, located in the NJ Center of Excellence, and a well-experienced management and leadership team.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $135.0M
- Funding stage: Private Equity
- Last round: Private Equity (Jun 2019)
- Website: nevakar.com
- Phone: 908-367-7400
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nevakar-47835 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.